Arylcyclohexylamine: Difference between revisions
m Dated {{No footnotes}}. (Build p612) |
|||
Line 68: | Line 68: | ||
| [[Phencyclidine]] (PCP) || Phenyl || Piperidine || - |
| [[Phencyclidine]] (PCP) || Phenyl || Piperidine || - |
||
|- |
|- |
||
| [[Rolicyclidine]] || Phenyl || Pyrrolidine || - |
| [[Rolicyclidine]] (PCPy) || Phenyl || Pyrrolidine || - |
||
|- |
|- |
||
| [[Tenocyclidine]] || 2-Thienyl || Piperidine || - |
| [[Tenocyclidine]] (TCP) || 2-Thienyl || Piperidine || - |
||
|- |
|- |
||
| [[Tiletamine]] || 2-Thienyl || NHEt || O |
| [[Tiletamine]] || 2-Thienyl || NHEt || O |
Revision as of 20:09, 24 July 2011
This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (June 2011) (Learn how and when to remove this message) |
Arylcyclohexylamines, also known as arylcyclohexamines or arylcyclohexanamines, are a chemical class of pharmaceutical, designer, and experimental drugs.
History
The arylcyclohexylamines were originally developed as anesthetics in the 1960s with ketamine and phencyclidine (PCP) being the first members of the class to be synthesized. The 1970s saw the debut of these compounds, especially PCP and its analogues, as illicit drugs of abuse due to their dissociative hallucinogenic and euphoriant effects. Since, the class has been expanded by scientific research into stimulant, analgesic, and neuroprotective agents, and also by clandestine chemists in search of novel recreational drugs.
Chemistry
An arylcyclohexylamine is composed of a cyclohexylamine unit with an aryl moiety attachment. The aryl group is often positioned geminal to the amine. In the simplest cases, the aryl moiety is typically a phenyl ring, sometimes with additional substitution. The amine is usually not primary, piperidino and pyrrolidino are examples of tertiary cycloalkylamines.
Pharmacology
Arylcyclohexylaminess varyingly possess NMDA receptor antagonist, dopamine reuptake inhibitor, and μ-opioid receptor agonist properties. Additionally, σ receptor agonist, nACh receptor antagonist, and D2 receptor agonist actions have been reported for some of these agents. Antagonism of the NMDA receptor confers anesthetic, anticonvulsant, neuroprotective, and dissociative effects, blockade of the dopamine transporter mediates stimulant and euphoriant effects as well as psychosis in high amounts, and activation of the μ-opioid receptor causes analgesic and euphoriant effects. Stimulation of the σ and D2 receptors may also contribute to hallucinogenic and psychotic effects.
Versatile agents with a wide range of possible pharmacological activities depending on the extent and range to which chemical modifications are implemented. The various choice of substitutions that are made allows for "fine-tuning" of the pharmacological profile that results. As examples, BTCP is a selective dopamine reuptake inhibitor,[1] PCP is primarily an NMDA antagonist, and BDPC is a superpotent μ-opioid agonist. Thus, radically different pharmacology is possible through different structural configurations.
List of arylcyclohexylamines
Compound | Aryl Substituent | N Group | Other |
2-HO-PCP[2] | Phenyl | Piperidine | 2-Hydroxy |
2-Me-PCP[3] | Phenyl | Piperidine | 2-Methyl(cyclohexyl) |
2-MeO-PCP[4] | Phenyl | Piperidine | 2-Methoxy |
3-HO-PCP | m-Hydroxyphenyl | Piperidine | - |
3-MeO-PCP | m-Methoxyphenyl | Piperidine | - |
Methoxydine (4-MeO-PCP) | p-Methoxyphenyl | Piperidine | - |
Arketamine | o-Chlorophenyl | NHMe | 2-Keto(cyclohexyl) |
BDPC | p-Bromophenyl | NHMe2 | 4-Phenethyl-4-hydroxy |
BTCP | Benzothiophen-2-yl | Piperidine | - |
Deschloroketamine | Phenyl | NHMe | 2-Keto |
Dieticyclidine | Phenyl | NEt2 | - |
Esketamine | o-Chlorophenyl | NHMe | 2-Keto |
Ethylketamine | o-Chlorophenyl | NHEt | O |
Eticyclidine | Phenyl | NHEt | - |
Gacyclidine | 2-Thienyl | Piperidine | 2-Methyl(cyclohexyl) |
Ketamine | o-Chlorophenyl | NHMe | O |
Methoxetamine | m-Methoxyphenyl | NHEt | O |
PCEEA[5] | Phenyl | NHC2H4OEt | - |
PCM | Phenyl | NHMe | - |
PCMEA[5] | Phenyl | NHCH2OEt | - |
PCPr[6] | Phenyl | PrnNH | - |
Phencyclamine | Phenyl | NH2 | - |
Phencyclidine (PCP) | Phenyl | Piperidine | - |
Rolicyclidine (PCPy) | Phenyl | Pyrrolidine | - |
Tenocyclidine (TCP) | 2-Thienyl | Piperidine | - |
Tiletamine | 2-Thienyl | NHEt | O |
References
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Arylcyclohexylamine" – news · newspapers · books · scholar · JSTOR (September 2010) (Learn how and when to remove this message) |
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 2544905, please use {{cite journal}} with
|pmid=2544905
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16229117, please use {{cite journal}} with
|pmid=16229117
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 1875352, please use {{cite journal}} with
|pmid=1875352
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16821645, please use {{cite journal}} with
|pmid=16821645
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19022226, please use {{cite journal}} with
|pmid=19022226
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18035363, please use {{cite journal}} with
|pmid=18035363
instead.
External links
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cathinones |
|
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|
Inhalational | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injection |
| ||||||||||||||
|
Opioids |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type | |||||||||||||||||
NSAIDs |
| ||||||||||||||||
Cannabinoids | |||||||||||||||||
Ion channel modulators |
| ||||||||||||||||
Myorelaxants | |||||||||||||||||
Others | |||||||||||||||||
|
GABAergics |
| ||||||
---|---|---|---|---|---|---|---|
Channel modulators |
| ||||||
Others |
| ||||||
|
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
|
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|
σ1 |
|
---|---|
σ2 |
|
Unsorted |
|
See also: Receptor/signaling modulators |